- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03951701
Evaluation of Interest of a Systematic Screening for Oncological Supportive Care Needs (DBSOS)
Evaluation of Interest of a Systematic Screening for Oncological Supportive Care
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The study will unfold in the followed day hospital's departments of the Paul Strauss Cancer Center (Strasbourg, France) : supportive care department, chemiotherapy department and radiotherapy department. The study is based on two questionnaires that include six sections : nutrition, social, psychologic, physiotherapy, pain and supportive care needs evaluation.
The first questionnaire gives information about the patient and allow to screen supportive care needs. It should be read by medical or paramedical staff who report the function of the reader and options that are proposed to the patient after reading the questionnaire.
The second questionnaire will be done after 4 to 6 weeks by a phone call from the clinical research nurse. The objective of this questionnaire is to determine what kind of care have been provided.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Strasbourg, Frankrike, 67065
- Centre Paul Strauss
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patient treated for a cancer
- Age ≥ 18 years old
- Receiving treatment (chemotherapy and/or radiotherapy) in day hospital and/or supportive care department
- Able to speak, read and understand French
- Able to communicate by phone
- Written informed consent obtained from the patient
- Registration in a national health care system
Exclusion Criteria:
- Minor or protected adult
- Pregnant or breastfeeding woman
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: observation cohort
Questionnaire to assess the supportive care needs
|
Evaluation of interest of a systematic screening for oncological supportive care needs
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Evaluation of using oncological supportive cares after evaluation of supportive care needs reviewed by a professional of health, by a phone call
Tidsramme: 4 to 6 weeks after baseline
|
Assess the percentage of using oncological supportive cares after evaluation of supportive care needs reviewed by a professional.
The use of supportive cares is evaluated with an hetero-questionnaire created for this study.
The hetero-questionnaire consists in a phone call to evaluate the evolution of each item of the self-assessment questionnaire (which includes 6 evaluations : a nutritional evaluation (10 items), a social evaluation (8 items), a psychologic evaluation (6 items), a physiological evaluation (7 items), a pain evaluation (4 items) and a supportive care needs evaluation (6 items)).
|
4 to 6 weeks after baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Evaluation of initial supportive care needs by the self-assessment questionnaire
Tidsramme: baseline
|
Assess the percentage of initial supportive care needs evaluated by the self-assessment questionnaire created for this study.
It includes evaluations : a nutritional evaluation (10 items), a social evaluation (8 items), a psychologic evaluation (6 items), a physiological evaluation (7 items), a pain evaluation (4 items) and a supportive care needs evaluation (6 items).
|
baseline
|
Assess the correlation between supportive care needs and age
Tidsramme: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to age by a Pearson Chi squared test
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the correlation between supportive care needs and sexe
Tidsramme: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to sexe by a Pearson Chi squared test.
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the correlation between supportive care needs and type of cancer
Tidsramme: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Correlate the percentage of supportive care needs to the type of cancer by a Pearson Chi squared test
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Compare the percentage of using a supportive care professional judgement in regard to read and unread questionnaires by medical staff
Tidsramme: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of using a supportive care when the medical staff read the completed questionnaire.
Assess the percentage of using a supportive care when the medical staff didn't read the completed questionnaire.
Then compare these values by using a T- test of Student.
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Compare the percentage of using a supportive care professional judgement in regard to the function of the medical staff member
Tidsramme: This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of using a supportive care when the medical staff who read the completed questionnaire is a doctor, a nurse, or an auxiliary nurse .
Then compare these values by using a T- test of Student
|
This analyse will be realized at the end of the study (9 weeks after baseline)
|
Assess the percentage of requirement to the physician during the study
Tidsramme: 4 to 6 weeks after baseline (by a phone call, at the same time than the hetero-questionnaire)
|
Assess the percentage of requirement to the physician during the study by asking each patient (by phone call)
|
4 to 6 weeks after baseline (by a phone call, at the same time than the hetero-questionnaire)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Véronique FRASIE, Md, Centre Paul Strauss
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2018-02
- 2018-A01425-50 (Annen identifikator: ANSM)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Støttende omsorgsbehov
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T terapikomplikasjonerItalia
-
The Lymphoma Academic Research OrganisationNovartis; Gilead SciencesRekrutteringHematopatologi Kvalifisert eller CAR-t-cellebehandlingFrankrike
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Har ikke rekruttert ennåAllogen, CAR-T, proteinsekvestrering, ikke-genredigertKina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Rekruttering
-
Shanghai International Medical CenterUkjentAvansert solid svulst | PD-1 antistoff | CAR-T-cellerKina
-
Ningbo Cancer HospitalUkjentAvanserte maligniteter | PD-1 antistoff | CAR-T-cellerKina
-
Ruijin HospitalRekruttering
-
Shanghai General Hospital, Shanghai Jiao Tong University...RekrutteringCAR-T Cell | Ph Positive ALLE | DasatinibKina
-
Insel Gruppe AG, University Hospital BernRekrutteringVaksineimmunitet hos mottakere av CAR-T-celleterapiSveits
-
Hannover Medical SchoolCytoSorbents, IncRekrutteringCytokinfrigjøringssyndrom | CAR-TTyskland, Sveits
Kliniske studier på Evaluation of the supportive care
-
University Hospital, Clermont-FerrandUkjent
-
Memorial Sloan Kettering Cancer CenterAvsluttetFamiliene eller pårørende til pasienter behandlet ved MSKCC for ikke-kutane plateepitelkarsinomer i | Øvre fordøyelseskanalForente stater
-
Hospices Civils de LyonRekrutteringLangsgående utvikling av atferd og dens underliggende nevrale korrelater hos spedbarn (MultiLongDev)Friske FrivilligeFrankrike
-
Medical College of WisconsinFullførtKommunikasjon | PasientengasjementForente stater
-
VA Greater Los Angeles Healthcare SystemRekrutteringPosttraumatisk stresslidelseForente stater
-
Boston University Charles River CampusRekrutteringPsykiske lidelser | Arbeid | Sysselsetting, støttet | MetakognisjonForente stater
-
University of British ColumbiaFullført
-
Ankara Yildirim Beyazıt UniversityFullførtOsteoporose | Sunn livsstil | Universitets studenterTyrkia
-
Henry M. Jackson Foundation for the Advancement...Uniformed Services University of the Health Sciences; ExThera Medical CorporationAktiv, ikke rekrutterende
-
Skin Analytics LimitedFullførtBasalcellekarsinom | Plateepitelkarsinom | Ondartet hudmelanom T0Forente stater, Italia